April 28, 2025 12:42 AM

Latest:

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Equinox Ups Its Offer For Calibre: Investors Said No!
First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
Agnico Eagle Q1 Earnings: Costs Go Down?!

the deep dive

Providing stock analysis for investors of the Canadian junior markets

Home
Latest
- Automotive
- Cannabis
- Commentary
- Full Analysis
- Gold
- Industrials
- Macro
- Oil
- Resources
- Technology
Resources
Energy
Technology
Coverage Companies
Verses AI
About
Contact Us

Trump Administration Defies Judge’s Order to Turn Back Deportation Flights of Venezuelan Migrants

Latest

Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Equinox Ups Its Offer For Calibre: Investors Said No!
First Quantum Q1 Earnings: Copper Major Still Bleeding Cash
Barrick’s $1 Billion Donlin Gold Sale: Why Everyone Agrees It’s a Win
Agnico Eagle Q1 Earnings: Costs Go Down?!
Why Gold Is Secretly Flooding Into The U.S. & Who’s Suppressing Silver?! | Andy Schectman
Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen – ESGOLD Corp.
Canada Is Nearly Last In Growth Among OECD Countries

Video

Teck Resources Q1 Earnings: Defying Copper Industry Weakness

April 27, 2025 4:40 PM Jay Lutz 0

Yesterday in our coverage of First Quantum Mining’s business we said it was a terrible time to be a copper

A Heart Disease Cure For Pericarditis? Phase 3 Trial Advances | David Elsley - Cardiol Therapeutics
Barrick's $1 Billion Donlin Gold Sale: Why Everyone Agrees It's a Win
Teck Resources Q1 Earnings: Defying Copper Industry Weakness
Newmont Q1 Earnings: Gold Boom Masks Production Problems
Gold @ $3500: All We Need Is $700 To Break Even! | Brad Kitchen - ESGOLD Corp.

News

Biotech Latest News

Cardiol Sees First Patient Enrolled Under Phase III MAVERIC Clinical Trial

April 17, 2025 7:59 AM Jay Lutz 0

Cardiol Therapeutics (TSX: CRDL) has reached a major milestone with the announcement that the first patients have been enrolled into a phase III clinical trial for its lead drug candidate, CardiolRx™.

Rua Gold Hits 13.3 g/t Gold, 8.1% Antimony Over 1.25 Metres At Auld Creek

April 16, 2025 8:29 AM Jay Lutz 0

Canadian Copper To Begin Exploration At Murray Brook East

April 15, 2025 10:30 AM Jay Lutz 0

About

Welcome to The Deep Dive, where we focus on providing investors of Canadian junior stock markets the knowledge they need to make smart investment decisions. We take a closer look at all data relating to organizations listed on the CSE and the TSX Venture to create quality stock analysis for investors.

Not a recommendation to buy or sell securities. Always do additional research and consult a professional before purchasing a security.

Leave a ReplyCancel reply